Abdulaziz Hamoudi: The Multicenter Randomized PROTECT-EST Trial Reports Impressive Results for SAP

Sep 7, 2026, 15:35 Abdulaziz Hamoudi, Business Development Manager at ENDOHUB group, shared a post on LinkedIn: 'Peptide-first for post-sphincterotomy bleeding? The multicenter randomized PROTECT-EST trial reports impressive results for self-assembling peptide (SAP) in persistent post-sphincterotomy oozing: 92.3 percent immediate hemostasis vs 76.9 percent with balloon tamponade 7.7 percent required rescue therapy vs 23.1 percent Promising evidence supporting a peptide-first strategy in therapeutic endoscopy. Proud to support the advancement of PuraStat self-assembling peptide technology in our region. Study.' Stay updated with Hemostasis Today.